← All diseases
Brain and nervous system
Parkinson's disease
Would you like to receive a message when there is new research about Parkinson's Disease? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as new research on Parkinson's Disease is published. View what Premium costs.
Publications (2880)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A comprehensive review on Jiao-tai-wan: Traditional application, pharmacokinetics, and therapeutic mechanisms in multiple disorders. (2026/12/06) ♡
- Nasal microenvironment self-responsive herbal hydrogel alleviates Parkinsonian pathology via the inhibition of α-synuclein liquid-liquid phase separation. (2026/12/01) ♡
- Generalized osteoporosis but not axial osteopenia is associated with cognitive impairment in Parkinson's disease. (2026/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. The footprint of ethnopharmacology in drug discovery (ISE-APSS2024). (2026/11/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chinese herbal and natural compounds for Parkinson's disease: Myth or truth. (2026/11/15) ♡
- Mitochondria-associated endoplasmic reticulum membranes and calcium ion exchange: A novel direction for aging and neurodegenerative diseases. (2026/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Natural monomer compounds in neurodegenerative diseases: Targeting ferroptosis and neuroinflammation. (2026/09/13) ♡
- Reproducible social phenotyping of 5xFAD mice in the Agora maze (Sociobox). (2026/09/13) ♡
- Targeting the NLRP3-NEK7 axis with rebamipide: Drug repurposing in Parkinson's disease. (2026/09/01) ♡
- When copper turns killer: Decoding copper dyshomeostasis and cuproptosis in neurodegenerative pathogenesis and precision metal interventions. (2026/09/01) ♡
- Deep learning-based cognitive impairment brain imaging analysis: New methods, new technologies, and new paradigms. (2026/09/01) ♡
- Wuzi Yanzong Pill improves Parkinson's disease via miR-146a-5p/USP3/NF-κB axis. (2026/09/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Benefits of 12-week self-paced training combined with melatonin supplementation on oxidative stress, inflammation, hyperlipidemia, and body composition in multiple sclerosis patients: A randomized controlled trial. (2026/09/01) ♡
- An injectable nanoreinforced hydrogel for combined GDNF-loaded nanoparticles and mesenchymal stem cell therapy in Parkinson's disease. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Stable Isotope-Resolved Metabolomics in Elucidating Mitochondrial Metabolic Reprogramming and Therapeutic Targets. (2026/09/01) ♡
- Selective loss of primary cilia and neurotrophic signaling in G51D α-synuclein mice highlights a common pathway to Parkinson's disease. (2026/08/18) ♡
- Rational Design of Multifunctional Tacrine Derivatives as Candidates for the Treatment of Alzheimer and Parkinson Diseases. (2026/08/14) ♡
- Voice Disorders as Early Biomarkers of Cognitive Decline. (2026/08/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fecal microbiota transplantation in Parkinson's disease: a systematic review. (2026/08/10) ♡
- The structural basis for LRRK2's activation and autoinhibition. (2026/08/10) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Chemical tools for inhibition and activity-based profiling of glucocerebrosidase in vitro and in vivo. (2026/08/10) ♡
- MCART1 (SLC25A51) deficiency exacerbates mitochondrial dysfunction during MPP(+)-induced complex I stress. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Amino Acid-Neurodegeneration Axis: Excitotoxicity and Oxidative Stress as Context-Dependent Amplifiers of Metabolic Dysfunction. (2026/08/10) ♡
- Stress, mood, and Parkinson's disease: selective dysregulation of corticotropin-releasing hormone and urocortin neurocircuits. (2026/08/10) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The adjunct use of Bifidobacterium animalis subsp. lactis BAMA-B06/BAu-B0111 improves the therapeutic efficacy of Liuwei'anxiao Capsule in alleviating constipation in Parkinson's Disease: A randomized controlled study. (2026/08/10) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Early-Onset Parkinson's Disease with 22q11.2 Microdeletion and Pathogenic GBA1 Variant. (2026/08/10) ♡
- Spatial-Spectral Fusion Enables Drug Repositioning by Capturing Indirect and Long-Range Associations in Biological Networks. (2026/08/10) ♡
- Seroprevalence Study of Toxoplasma gondii Infection in Psychiatric and Neurological Disorders. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Semaglutide as a potential neuroprotective agent for neurological and neurodegenerative disorders: Mechanisms, preclinical evidence, and translational challenges and opportunities. (2026/08/10) ♡
- Factors associated with selection of total hip arthroplasty versus hemiarthroplasty for femoral neck fracture in older adults: a nationwide analysis of 99,084 cases. (2026/08/10) ♡
- 7 Tesla MRI with Quantitative Susceptibility Mapping: qualitative grading and quantitative focal measurements of the substantia nigra as a potential biomarker for Parkinson's disease. (2026/08/10) ♡
- Panax quinquefolius ginsenosides for neuroprotection in Parkinson's disease via TNF-α inhibition. (2026/08/10) ♡
- Factors associated with the dual-task cost of walking in people with Parkinson's disease. (2026/08/10) ♡
- Tardive blepharospasm. (2026/08/10) ♡
- Frequency and outcome of PEG tube implantations in hospitalized Parkinson's disease patients. (2026/08/09) ♡
- Continuous theta burst stimulation delays L-DOPA-induced dyskinesia progression and ameliorates orolingual dyskinesia with concomitant reduction of striatal FosB/ΔFosB and neuroinflammation. (2026/08/09) ♡
- Peripheral GDF15 as an early biomarker for brain disorders: A large prospective cohort study. (2026/08/09) ♡
- Insulin like growth factor and cytokine signalling predict future cognitive impairment in Parkinson's disease. (2026/08/09) ♡
- Gait-cycle-locked cortico-subthalamic signatures underlying freezing of gait and their modulation in Parkinson's disease. (2026/08/09) ♡
- Early Longitudinal Brain Network Changes in Huntington's Disease Before Clinical Motor Onset. (2026/08/09) ♡
- Combined Transcranial Sonography of the Substantia Nigra and (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Parkinson's Disease and Atypical Parkinsonian Syndromes. (2026/08/09) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Palatal Tremor of Progressive Ataxia with Palatal Tremor Can Disappear over Time: Pathophysiological Considerations. (2026/08/09) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. COVID-19 Amplifies Sex-Specific Dopamine and Glial Responses in a Parkinson's Disease Mouse Model. (2026/08/09) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Dual Anatomical Targeting or Dual-Target Stimulation in Tremor-Dominant Parkinson's Disease? (2026/08/09) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: "Dual Anatomical Targeting or Dual-Target Stimulation in Tremor-Dominant Parkinson's Disease?". (2026/08/09) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: "Alkaline phosphatases as a potential source of variability in foslevodopa response: Muscles beyond pharmacokinetics". (2026/08/09) ♡
- The Incidence of Sensorineural Hearing Loss Diagnoses in People with and without Parkinson's Disease. (2026/08/08) ♡
- Real-world gait changes preceding Parkinson's disease diagnosis in a population-scale UK biobank cohort. (2026/08/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic Reprogramming-Driven Neuroimmunoregulation: Key Mechanisms and Therapeutic Opportunities and Challenges in Central Nervous System Disorders. (2026/08/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The gut-brain-mitophagy axis: Urolithin A as a transcriptional activator of Parkin in Alzheimer's and Parkinson's diseases. (2026/08/08) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.